Literature DB >> 1373022

Selective loss of nigral neurons in Alzheimer's disease: a morphometric study.

T Uchihara1, H Kondo, K Kosaka, H Tsukagoshi.   

Abstract

Loss of neurons from the substantia nigra (SN), which is sometimes observed in Alzheimer's disease (AD), was quantitatively analyzed in 10 cases of presenile AD and 19 age-matched controls. On sections from the upper and lower portions of the SN, the pigmented zone (zona compacta) and the non-pigmented zone (zona reticulata) were delineated, and these zones were partitioned into quarters: medial, mid-medial, mid-lateral and lateral. This approach clarified topographical preference of neuronal depletion in the SN of AD; namely (1) pigmented neurons were more severely affected than non-pigmented neurons, (2) neuronal depletion was more marked in the lower SN (-38%, P less than 0.001), where the pigmented neurons in the medial quarter were most severely affected (-51%, P less than 0.001), (3) in the upper SN (neuronal loss: -21%, P less than 0.01), the pigmented neurons in the mid-medial quarter were most severely affected (-43%, P less than 0.01). These findings suggest that some groups of nigral neurons are primarily involved in presenile AD. Gallyas staining after bleaching of melanin pigments uncovered a large number of neurofibrillary tangles (NFTs) mainly in the pigmented zone, especially in the medial quarter. A large number of NFTs, scarse senile plaques, and substantial depletion of neurons form an unique combination of Alzheimer pathology in the SN not well recognized so far.

Entities:  

Mesh:

Year:  1992        PMID: 1373022     DOI: 10.1007/bf00296789

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  31 in total

1.  Alzheimer's neurofibrillary changes. A topographic study.

Authors:  A HIRANO; H M ZIMMERMAN
Journal:  Arch Neurol       Date:  1962-09

2.  The brain-stem lesions in Parkinsonism.

Authors:  J G GREENFIELD; F D BOSANQUET
Journal:  J Neurol Neurosurg Psychiatry       Date:  1953-11       Impact factor: 10.154

3.  Extrapyramidal signs in dementia of Alzheimer type.

Authors:  P J Tyrrell; M N Rossor
Journal:  Lancet       Date:  1989-10-14       Impact factor: 79.321

4.  Clinically diagnosed Alzheimer's disease: autopsy results in 150 cases.

Authors:  C L Joachim; J H Morris; D J Selkoe
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

5.  Parkinson's disease in patients with Alzheimer's disease.

Authors:  J Leverenz; S M Sumi
Journal:  Arch Neurol       Date:  1986-07

Review 6.  Quantitative changes in some subcortical nuclei in aging, Alzheimer's disease and Parkinson's disease.

Authors:  K Jellinger
Journal:  Neurobiol Aging       Date:  1987 Nov-Dec       Impact factor: 4.673

7.  The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome.

Authors:  W R Gibb; C Q Mountjoy; D M Mann; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

8.  Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease.

Authors:  E Hirsch; A M Graybiel; Y A Agid
Journal:  Nature       Date:  1988-07-28       Impact factor: 49.962

9.  Extrapyramidal features in advanced Down's syndrome: clinical evaluation and family history.

Authors:  P Vieregge; G Ziemens; M Freudenberg; A Piosinski; A Muysers; B Schulze
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-01       Impact factor: 10.154

10.  Pathologic correlates of dementia in Parkinson's disease.

Authors:  H C Chui; J A Mortimer; U Slager; C Zarow; W Bondareff; D D Webster
Journal:  Arch Neurol       Date:  1986-10
View more
  8 in total

1.  Alzheimer-type pathology in melanin-bleached sections of substantia nigra.

Authors:  T Uchihara; H Kondo; K Ikeda; K Kosaka
Journal:  J Neurol       Date:  1995-08       Impact factor: 4.849

2.  Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer's disease - Hyperphosphorylation and cleavage of 4- and 3-repeat tau.

Authors:  Hiroki Fujii; Tetsuya Takahashi; Tomoya Mukai; Shigeru Tanaka; Naohisa Hosomi; Hirofumi Maruyama; Norio Sakai; Masayasu Matsumoto
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 3.  Relevance of the glutathione system in temporal lobe epilepsy: evidence in human and experimental models.

Authors:  Noemí Cárdenas-Rodríguez; Elvia Coballase-Urrutia; Claudia Pérez-Cruz; Hortencia Montesinos-Correa; Liliana Rivera-Espinosa; Aristides Sampieri; Liliana Carmona-Aparicio
Journal:  Oxid Med Cell Longev       Date:  2014-11-30       Impact factor: 6.543

4.  A platform for stereological quantitative analysis of the brain-wide distribution of type-specific neurons.

Authors:  Chen Zhang; Cheng Yan; Miao Ren; Anan Li; Tingwei Quan; Hui Gong; Jing Yuan
Journal:  Sci Rep       Date:  2017-10-30       Impact factor: 4.379

5.  Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology.

Authors:  Vanessa Laversenne; Sameer Nazeeruddin; Emma C Källstig; Philippe Colin; Christel Voize; Bernard L Schneider
Journal:  Acta Neuropathol Commun       Date:  2020-11-23       Impact factor: 7.801

6.  Simplification of the modified Gallyas method.

Authors:  Nobuo Kuninaka; Minato Kawaguchi; Masaru Ogawa; Ayako Sato; Kunimasa Arima; Shigeo Murayama; Yuko Saito
Journal:  Neuropathology       Date:  2014-09-01       Impact factor: 1.906

Review 7.  Allopregnanolone and neurogenesis in the nigrostriatal tract.

Authors:  Jun Ming Wang
Journal:  Front Cell Neurosci       Date:  2014-08-12       Impact factor: 5.505

8.  Large-scale localization of touching somas from 3D images using density-peak clustering.

Authors:  Shenghua Cheng; Tingwei Quan; Xiaomao Liu; Shaoqun Zeng
Journal:  BMC Bioinformatics       Date:  2016-09-15       Impact factor: 3.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.